|
|
Volumn 2, Issue 4, 2000, Pages 290-296
|
|
Percutaneous coronary intervention versus medical therapy for coronary heart disease.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
HEPTANOIC ACID DERIVATIVE;
HYPOCHOLESTEROLEMIC AGENT;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NITRATE;
PYRROLE DERIVATIVE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
FEMALE;
HUMAN;
MALE;
METABOLISM;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK FACTOR;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTICHOLESTEREMIC AGENTS;
CALCIUM CHANNEL BLOCKERS;
CHOLESTEROL, LDL;
CORONARY DISEASE;
FEMALE;
HEPTANOIC ACIDS;
HUMANS;
MALE;
NITRATES;
PYRROLES;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
TREATMENT OUTCOME;
|
|
EID: 0034230517
PISSN: 15233804
EISSN: None
Source Type: Journal
DOI: 10.1007/s11883-000-0061-9 Document Type: Review |
|
Times cited : (9)
|
|
References (26)
|
